In individuals with MASLD, increased secretion of diabetogenic hepatokines such as retinol-binding protein 4 (RBP4), fetuin-A, and fibroblast growth factor 21 (FGF-21) has been observed. The gene discussed is RBP4; the disease is metabolic dysfunction-associated steatotic liver disease.